Renal Function Outcomes with Everolimus Plus Reduced-Exposure Tacrolimus in de Novo Living Donor Liver Transplantation: 24-month results from the H2307 study

被引：5

作者：

Suh, Kyung Suk ^{[1
]}

Jeng, Long-Bin ^{[2
]}

Soin, Arvinder Singh ^{[3
]}

Lee, Wei-Chen ^{[4
]}

Lee, Sung Gyu ^{[5
]}

Grant, David ^{[6
]}

Yoshizumi, Tomoharu ^{[7
]}

El Meteini, Mahmoud ^{[8
]}

Meier, Matthias ^{[9
]}

Kochuparampil, Jossy ^{[9
]}

Sips, Carole ^{[9
]}

Kaneko, Shuhei ^{[10
]}

Levy, Gary ^{[6
]}

机构：

[1] Seoul Natl Univ, Coll Med, Seoul, South Korea

[2] China Med Univ Hosp, Taichung, Taiwan

[3] Medanta, Medic Hosp, Gurgaon, India

[4] Chang Gung Mem Hosp, Taoyuan, Taiwan

[5] Asan Med Ctr, Seoul, South Korea

[6] Univ Toronto, Toronto, ON, Canada

[7] Kyushu Univ Hosp, Fukuoka, Fukuoka, Japan

[8] Ain Shams Univ, Cairo, Egypt

[9] Novartis Pharma AG, Basel, Switzerland

[10] Novartis Pharma KK, Tokyo, Japan

来源：

关键词：

D O I：

10.1097/01.tp.0000542566.18089.a5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

315.4

引用

页码：S21 / S22

页数：2